Ibrance rejected for health insurance benefits
The registration of Ibrance Cap(Pfizer Pharmaceuticals Korea), a breast cancer treatment, for the health insurance benefits fell through.
The Health Insurance Benefit Evaluation Committee conducted an health insurance benefit evaluation on 6 products of 5 companies on the 8th and decided the hea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
